Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
作者信息
Mahindroo Neeraj, Punchihewa Chandanamali, Fujii Naoaki
机构信息
Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
出版信息
J Med Chem. 2009 Jul 9;52(13):3829-45. doi: 10.1021/jm801420y.
Abstract
摘要
相似文献
1
Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
J Med Chem. 2009 Jul 9;52(13):3829-45. doi: 10.1021/jm801420y.
2
Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?
Cancer Cell. 2008 Oct 7;14(4):281-3. doi: 10.1016/j.ccr.2008.09.007.
3
Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Cancer Chemother Pharmacol. 2016 Mar;77(3):495-505. doi: 10.1007/s00280-016-2962-5. Epub 2016 Jan 19.
4
The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
Oncotarget. 2011 Aug;2(8):638-45. doi: 10.18632/oncotarget.310.
5
Targeting GLI factors to inhibit the Hedgehog pathway.
Trends Pharmacol Sci. 2015 Aug;36(8):547-58. doi: 10.1016/j.tips.2015.05.006. Epub 2015 Jun 10.
6
Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
J Thorac Cardiovasc Surg. 2014 Jan;147(1):508-16. doi: 10.1016/j.jtcvs.2013.08.035. Epub 2013 Oct 4.
7
New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha.
Bioorg Med Chem Lett. 2011 Jan 15;21(2):718-22. doi: 10.1016/j.bmcl.2010.11.126. Epub 2010 Dec 5.
8
Targeting GLI proteins in human cancer by small molecules (WO2014116651 A1): a patent evaluation.
Expert Opin Ther Pat. 2015 May;25(5):613-7. doi: 10.1517/13543776.2015.1019467. Epub 2015 Mar 15.
9
[Hedgehog signaling in the pathogenesis of neuro-oncology diseases].
Biomed Khim. 2015 May-Jun;61(3):332-42. doi: 10.18097/PBMC20156103332.
10
Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer.
Cells. 2019 Apr 29;8(5):394. doi: 10.3390/cells8050394.
引用本文的文献
1
Probing the biological efficacy and mechanistic pathways of natural compounds in breast cancer therapy via the Hedgehog signaling pathway.
J Pharm Anal. 2025 Apr;15(4):101143. doi: 10.1016/j.jpha.2024.101143. Epub 2024 Nov 13.
2
GANT61 surmounts drug resistance of ADR by upregulating lysosome activities and reducing BCL2 expression in HL-60/ADR cells.
Cancer Cell Int. 2024 Dec 26;24(1):430. doi: 10.1186/s12935-024-03626-5.
3
Targeting GLI1 and BAX by nanonoscapine could impede prostate adenocarcinoma progression.
Sci Rep. 2024 Aug 16;14(1):18977. doi: 10.1038/s41598-024-65968-4.
4
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.
Int J Mol Sci. 2023 Oct 14;24(20):15173. doi: 10.3390/ijms242015173.
5
The role of Hedgehog and Notch signaling pathway in cancer.
Mol Biomed. 2022 Dec 15;3(1):44. doi: 10.1186/s43556-022-00099-8.
6
Novel Approaches in Non-Melanoma Skin Cancers-A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC).
Cells. 2022 Oct 13;11(20):3210. doi: 10.3390/cells11203210.
7
Chemopreventive efficacy of silibinin against basal cell carcinoma growth and progression in UVB-irradiated Ptch+/- mice.
Carcinogenesis. 2022 Jun 27;43(6):557-570. doi: 10.1093/carcin/bgac023.
8
Hedgehog Pathway Inhibitors against Tumor Microenvironment.
Cells. 2021 Nov 12;10(11):3135. doi: 10.3390/cells10113135.
9
Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma.
J Clin Med. 2020 Sep 18;9(9):3010. doi: 10.3390/jcm9093010.
10
Silibinin and non-melanoma skin cancers.
J Tradit Complement Med. 2020 Feb 6;10(3):236-244. doi: 10.1016/j.jtcme.2020.02.003. eCollection 2020 May.
本文引用的文献
1
A small molecule that binds Hedgehog and blocks its signaling in human cells.
Nat Chem Biol. 2009 Mar;5(3):154-6. doi: 10.1038/nchembio.142. Epub 2009 Jan 18.
2
GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.
Genes Dev. 2009 Jan 1;23(1):24-36. doi: 10.1101/gad.1753809.
3
Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.
Bioorg Med Chem Lett. 2009 Jan 15;19(2):328-31. doi: 10.1016/j.bmcl.2008.11.096. Epub 2008 Dec 3.
4
Role and regulation of human tumor suppressor SUFU in Hedgehog signaling.
Adv Cancer Res. 2008;101:29-43. doi: 10.1016/S0065-230X(08)00402-8.
5
Role of hedgehog signaling in ovarian cancer.
Clin Cancer Res. 2008 Dec 1;14(23):7659-66. doi: 10.1158/1078-0432.CCR-08-1414.
6
Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes.
Int J Cancer. 2009 Jan 1;124(1):109-19. doi: 10.1002/ijc.23929.
7
Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana.
Bioorg Med Chem. 2008 Nov 1;16(21):9420-4. doi: 10.1016/j.bmc.2008.09.053. Epub 2008 Sep 24.
8
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists.
J Med Chem. 2008 Nov 13;51(21):6646-9. doi: 10.1021/jm8008508. Epub 2008 Oct 9.
9
Basal cell carcinomas: attack of the hedgehog.
Nat Rev Cancer. 2008 Oct;8(10):743-54. doi: 10.1038/nrc2503.
10
Cancer: Hedgehog's other great trick.
Nature. 2008 Sep 18;455(7211):293-4. doi: 10.1038/455293a.
Zotero 插件